20-alpha-Hydroxysteroid Dehydrogenase

Subscribe to Selected New Research on 20-alpha-Hydroxysteroid Dehydrogenase

11 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: An enzymes that catalyzes the reversible reduction-oxidation reaction of 20-alpha-hydroxysteroids, such as from PROGESTERONE to 20-ALPHA-DIHYDROPROGESTERONE.

Also Known As:

17 beta, 20 alpha-Hydroxysteroid Dehydrogenase; 20 alpha-Hydroxysteroid Dehydrogenase; 20-alpha-HSD; NADPH-Dependent 20 alpha-Hydroxysteroid Oxidoreductase; 17 beta, 20 alpha Hydroxysteroid Dehydrogenase; 20 alpha HSD; 20 alpha Hydroxysteroid Dehydrogenase; NADPH Dependent 20 alpha Hydroxysteroid Oxidoreductase

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1

Enzymes: 24340

Oxidoreductases: 6825

Alcohol Oxidoreductases

Hydroxysteroid Dehydrogenases: 6

20-Hydroxysteroid Dehydrogenases

20-alpha-Hydroxysteroid Dehydrogenase: 11

20 alpha-dihydroprogesterone dehydrogenase

Related Diseases

1.	Temporal Lobe Epilepsy 04/01/2003 - "The aim of the present study was to investigate the mRNA expression of 5 alpha-reductase 1 as well as 3 alpha-HSD 1, 2, 3 and 20 alpha-HSD in brain tissue from patients with pharmacoresistant temporal lobe epilepsy (TLE)" Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 06/01/1994 - "Thus, 20 alpha-HSD activity was found in neoplastic tissues at a considerable high rate and the activity seemed to be higher in pathologically malignant tumors." 06/01/1994 - "Comparing with the activity of normal tissues examined, the corresponding tumor tissues showed significantly higher 20 alpha-HSD activities" 06/01/1994 - "Among these tumors, mixed tumor types demonstrated the higher 20 alpha-HSD activity than epithelial and non-epithelial types, and malignant tumors of each tissue type showed slightly but not significantly higher 20 alpha-HSD activities comparing with the corresponding benign ones" 06/01/1994 - "Forty-eight of 57 tumor samples were shown to possess 20 alpha-HSD activity" 06/01/1994 - "20 alpha-hydroxysteroid dehydrogenase activity in canine spontaneous neoplasms." Get all the results and reference details, order at left...
3.	Lymphoma (Lymphomas) 03/01/1985 - "The subset of T-cell involved was influenced by the genotype since lymphomas arising after the transfer of CBA and BALB/c spleens were TdT positive and 20 alpha-hydroxysteroid dehydrogenase positive, respectively" 02/15/1982 - "The T-cell enzyme markers, terminal deoxy-nucleotidyltransferase (TDT) and 20 alpha hydroxysteroid dehydrogenase (20 alpha SDH), were used to classify lymphomas induced by the Moloney leukemia virus (M-MuLV)" 03/01/1985 - "Such lymphomas arise from at least two subsets of T-cells, one terminal deoxynucleotidyl transferase (TdT) positive and the other 20 alpha-hydroxysteroid dehydrogenase positive" Get all the results and reference details, order at left...
4.	Syndrome 11/01/1991 - "20 alpha-hydroxysteroid dehydrogenase expression in a murine virus-induced myeloproliferative syndrome." Get all the results and reference details, order at left...
5.	Osteosarcoma (Osteogenic Sarcoma) 07/01/1996 - "Effects of 20 alpha-hydroxysteroid dehydrogenase and its inhibitors on canine osteosarcoma cell growth in vitro." 07/01/1996 - "From these results, POS osteosarcoma cells have 20 alpha-HSD, which might play an important role in tumor cell growth against the cell toxicity of progesterone." Get all the results and reference details, order at left...
7 Diseases and 11 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cholestenone 5 alpha-Reductase (5 alpha-Reductase)
2.	Messenger RNA (mRNA)
3.	3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)
4.	NADP (NADPH)
5.	Progesterone
6.	Enzymes
7.	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
8.	DEAE-Cellulose
9.	anthracene
9 Drugs and Important Bio-Agents and 7 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>